Annual Report

The report covers BRAIN Biotech's 2024/25 Group performance, including revenue of EUR 49,623 thousand and 281 employees. It highlights implementation of a double materiality analysis in accordance with ESRS and assigns ESG strategy responsibility to the Management and Supervisory Boards. The company commissioned photovoltaic systems at Zwingenberg and Cardiff and reports a path to net zero by 2050. It also reports active membership of the UN Global Compact and annual progress reporting.